Filing Details
- Accession Number:
- 0001179110-14-004581
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-05 19:05:53
- Reporting Period:
- 2014-03-03
- Filing Date:
- 2014-03-05
- Accepted Time:
- 2014-03-05 19:05:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1080014 | Theravance Inc | THRX | Pharmaceutical Preparations (2834) | 943265960 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1302448 | J Bradford Shafer | Theravance, Inc. 901 Gateway Boulevard South San Francisco CA 94080 | Sr Vp, Gen. Counsel, Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-03-03 | 30,967 | $9.69 | 326,731 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-03-03 | 65,806 | $9.69 | 392,537 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-03-03 | 64,006 | $36.72 | 328,531 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-03-03 | 1,800 | $37.23 | 326,731 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-03-03 | 30,967 | $0.00 | 30,967 | $9.69 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-03-03 | 65,806 | $0.00 | 65,806 | $9.69 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-03-28 | No | 4 | M | Direct | |
| 0 | 2014-03-28 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,750 | Indirect | by child's trust |
| Common Stock | 2,750 | Indirect | by child's trust |
| Common Stock | 2,750 | Indirect | by child's trust |
Footnotes
- DISPOSITIONS MADE PURSUANT TO A PLAN INTENDED TO COMPLY WITH RULE 10b5-1(c).
- This transaction was executed in multiple trades at prices from $36.19 to $37.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices from $37.19 to $37.24. The price reported above reflects the weighted average sale price.
- Shares held in trust for the benefit of a child of the reporting person. Reporting person is a trustee of the trust. Reporting person disclaims beneficial ownership of these shares.
- Exercisable immediately.
Billionaire Hedge Funds
